Enalapril Pimobendan Oral Oil Suspension

Enalapril Maleate / Pimobendan Oral Oil Suspension
Prescribed For: Dogs and Cats
May be Prescribed For: Congestive Heart Failure

Pimobendan Oral Suspension
Prescribed For: Dogs and Cats
May be Prescribed For: Congestive Heart Failure

Enalapril is an angiotensin-converting enzyme (ACE) inhibitor that is commonly prescribed by veterinarians to treat high blood pressure in cats and dogs. It also can be used in conjunction with other medications to treat mild to severe heart failure

Enalapril Maleate / Pimobendan may be prescribed for

• Congestive Heart Failure

One of the dosage forms available for Enalapril Maleate / Pimobendan is Oral Oil Suspension. Wedgewood Pharmacy’s oral suspensions and solutions are a familiar and convenient dosage form. Oral suspensions and solutions can be administered directly into the mouth using a dosing syringe or mixed with a small amount of food. They offer a wide range of flavoring options, and flexible dosing adjustments.

32 strength combinations of Enalapril Maleate / Pimobendan Oral Oil Suspension are available.

• Enalapril Maleate from 1.25 mg/ml to 15 mg/ml
• Pimobendan from 0.625 mg/ml to 10 mg/ml

Pimobendan may be prescribed for

• Congestive Heart Failure

One of the dosage forms available for Pimobendan is Oral Suspension. Wedgewood Pharmacy’s oral suspensions and solutions are a familiar and convenient dosage form. Oral suspensions and solutions can be administered directly into the mouth using a dosing syringe or mixed with a small amount of food. They offer a wide range of flavoring options, and flexible dosing adjustments.

70 strengths of Pimobendan Oral Suspension are available, ranging from 0.5 mg/ml to 40 mg/ml.

Pimobendan transdermal gel is a relatively new and unique inodilator (inotropic, mixed vasodilator). Its positive inotropic actions are caused by both inhibition of phosphodiesterase III and increased sensitization of myocardial contractile proteins to calcium. Digoxin and other inotropic drugs increase cardiac contractility by increasing the amount of intracellular calcium.

Pimobendan improves systolic efficiency without the negative pathway of increasing intracellular calcium. Pimobendan increases cardiac output and reduces both the cardiac preload and afterload. It is usually used in conjunction with other cardiac drugs (furosemide, digoxin, and enalapril). Pimobendan is metabolized by the liver.